ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Acute Myeloid Leukemia Biomarker Detection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-0Z14347
Home | Market Reports | Health| Health Conditions| Cancer
Global Acute Myeloid Leukemia Biomarker Detection Market Research Report 2023
BUY CHAPTERS

Global Acute Myeloid Leukemia Biomarker Detection Market Research Report 2025

Code: QYRE-Auto-0Z14347
Report
May 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Bio-Rad Laboratories Inc
Laboratory Corporation of America Holdings
Danaher
Neogenomics Laboratories
QIAGEN N V
Thermo Fisher Scientific Inc
GeneTex
Genmark Saghlk Orinleri
Medaysis Company

Acute Myeloid Leukemia Biomarker Detection Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Acute Myeloid Leukemia Biomarker Detection Market

Acute Myeloid Leukemia Biomarker Detection Market

The global market for Acute Myeloid Leukemia Biomarker Detection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Acute myeloid leukemia is a malignant neoplastic disease that usually results from the deterioration of stem cells in the bone marrow. Biomarker detection is a method that can detect specific molecular or genetic variations of leukemia cells, which can be used to diagnose AML, evaluate patient prognosis, and guide the selection of treatment options.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Acute Myeloid Leukemia Biomarker Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Myeloid Leukemia Biomarker Detection.
The Acute Myeloid Leukemia Biomarker Detection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acute Myeloid Leukemia Biomarker Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Myeloid Leukemia Biomarker Detection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Acute Myeloid Leukemia Biomarker Detection Market Report

Report Metric Details
Report Name Acute Myeloid Leukemia Biomarker Detection Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
  • Hospital
  • Research Institutions
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott Laboratories, Bio-Rad Laboratories, Inc., Genmark Saghlk Orinleri, Laboratory Corporation of America Holdings, Danaher, Medaysis Company, NeoGenomics Laboratories, QIAGEN N.V., Thermo Fisher Scientific, Inc., GeneTex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Acute Myeloid Leukemia Biomarker Detection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Acute Myeloid Leukemia Biomarker Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Acute Myeloid Leukemia Biomarker Detection Market report?

Ans: The main players in the Acute Myeloid Leukemia Biomarker Detection Market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Genmark Saghlk Orinleri, Laboratory Corporation of America Holdings, Danaher, Medaysis Company, NeoGenomics Laboratories, QIAGEN N.V., Thermo Fisher Scientific, Inc., GeneTex

What are the Application segmentation covered in the Acute Myeloid Leukemia Biomarker Detection Market report?

Ans: The Applications covered in the Acute Myeloid Leukemia Biomarker Detection Market report are Hospital, Research Institutions, Other

What are the Type segmentation covered in the Acute Myeloid Leukemia Biomarker Detection Market report?

Ans: The Types covered in the Acute Myeloid Leukemia Biomarker Detection Market report are Next Generation Sequencing Technology, PCR Detection Technology

Recommended Reports

Blood Testing Devices

Hematology Equipment

Leukemia Diagnostics

1 Acute Myeloid Leukemia Biomarker Detection Market Overview
1.1 Product Definition
1.2 Acute Myeloid Leukemia Biomarker Detection by Type
1.2.1 Global Acute Myeloid Leukemia Biomarker Detection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Next Generation Sequencing Technology
1.2.3 PCR Detection Technology
1.3 Acute Myeloid Leukemia Biomarker Detection by Application
1.3.1 Global Acute Myeloid Leukemia Biomarker Detection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Other
1.4 Global Acute Myeloid Leukemia Biomarker Detection Market Size Estimates and Forecasts
1.4.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue 2020-2031
1.4.2 Global Acute Myeloid Leukemia Biomarker Detection Sales 2020-2031
1.4.3 Global Acute Myeloid Leukemia Biomarker Detection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Acute Myeloid Leukemia Biomarker Detection Market Competition by Manufacturers
2.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Acute Myeloid Leukemia Biomarker Detection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Product Type & Application
2.7 Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Date of Enter into This Industry
2.8 Global Acute Myeloid Leukemia Biomarker Detection Market Competitive Situation and Trends
2.8.1 Global Acute Myeloid Leukemia Biomarker Detection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Acute Myeloid Leukemia Biomarker Detection Players Market Share by Revenue
2.8.3 Global Acute Myeloid Leukemia Biomarker Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Acute Myeloid Leukemia Biomarker Detection Market Scenario by Region
3.1 Global Acute Myeloid Leukemia Biomarker Detection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Acute Myeloid Leukemia Biomarker Detection Sales by Region: 2020-2031
3.2.1 Global Acute Myeloid Leukemia Biomarker Detection Sales by Region: 2020-2025
3.2.2 Global Acute Myeloid Leukemia Biomarker Detection Sales by Region: 2026-2031
3.3 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Region: 2020-2031
3.3.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Region: 2020-2025
3.3.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Region: 2026-2031
3.4 North America Acute Myeloid Leukemia Biomarker Detection Market Facts & Figures by Country
3.4.1 North America Acute Myeloid Leukemia Biomarker Detection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2020-2031)
3.4.3 North America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Acute Myeloid Leukemia Biomarker Detection Market Facts & Figures by Country
3.5.1 Europe Acute Myeloid Leukemia Biomarker Detection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Acute Myeloid Leukemia Biomarker Detection Sales by Country (2020-2031)
3.5.3 Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acute Myeloid Leukemia Biomarker Detection Market Facts & Figures by Region
3.6.1 Asia Pacific Acute Myeloid Leukemia Biomarker Detection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Acute Myeloid Leukemia Biomarker Detection Sales by Region (2020-2031)
3.6.3 Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Acute Myeloid Leukemia Biomarker Detection Market Facts & Figures by Country
3.7.1 Latin America Acute Myeloid Leukemia Biomarker Detection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2020-2031)
3.7.3 Latin America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Market Facts & Figures by Country
3.8.1 Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Acute Myeloid Leukemia Biomarker Detection Sales by Type (2020-2031)
4.1.1 Global Acute Myeloid Leukemia Biomarker Detection Sales by Type (2020-2025)
4.1.2 Global Acute Myeloid Leukemia Biomarker Detection Sales by Type (2026-2031)
4.1.3 Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2020-2031)
4.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Type (2020-2031)
4.2.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Type (2020-2025)
4.2.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Type (2026-2031)
4.2.3 Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Type (2020-2031)
4.3 Global Acute Myeloid Leukemia Biomarker Detection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Acute Myeloid Leukemia Biomarker Detection Sales by Application (2020-2031)
5.1.1 Global Acute Myeloid Leukemia Biomarker Detection Sales by Application (2020-2025)
5.1.2 Global Acute Myeloid Leukemia Biomarker Detection Sales by Application (2026-2031)
5.1.3 Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2020-2031)
5.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Application (2020-2031)
5.2.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Application (2020-2025)
5.2.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Application (2026-2031)
5.2.3 Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Application (2020-2031)
5.3 Global Acute Myeloid Leukemia Biomarker Detection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Company Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Bio-Rad Laboratories, Inc.
6.2.1 Bio-Rad Laboratories, Inc. Company Information
6.2.2 Bio-Rad Laboratories, Inc. Description and Business Overview
6.2.3 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolio
6.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
6.3 Genmark Saghlk Orinleri
6.3.1 Genmark Saghlk Orinleri Company Information
6.3.2 Genmark Saghlk Orinleri Description and Business Overview
6.3.3 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product Portfolio
6.3.5 Genmark Saghlk Orinleri Recent Developments/Updates
6.4 Laboratory Corporation of America Holdings
6.4.1 Laboratory Corporation of America Holdings Company Information
6.4.2 Laboratory Corporation of America Holdings Description and Business Overview
6.4.3 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product Portfolio
6.4.5 Laboratory Corporation of America Holdings Recent Developments/Updates
6.5 Danaher
6.5.1 Danaher Company Information
6.5.2 Danaher Description and Business Overview
6.5.3 Danaher Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Danaher Acute Myeloid Leukemia Biomarker Detection Product Portfolio
6.5.5 Danaher Recent Developments/Updates
6.6 Medaysis Company
6.6.1 Medaysis Company Company Information
6.6.2 Medaysis Company Description and Business Overview
6.6.3 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product Portfolio
6.6.5 Medaysis Company Recent Developments/Updates
6.7 NeoGenomics Laboratories
6.7.1 NeoGenomics Laboratories Company Information
6.7.2 NeoGenomics Laboratories Description and Business Overview
6.7.3 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolio
6.7.5 NeoGenomics Laboratories Recent Developments/Updates
6.8 QIAGEN N.V.
6.8.1 QIAGEN N.V. Company Information
6.8.2 QIAGEN N.V. Description and Business Overview
6.8.3 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product Portfolio
6.8.5 QIAGEN N.V. Recent Developments/Updates
6.9 Thermo Fisher Scientific, Inc.
6.9.1 Thermo Fisher Scientific, Inc. Company Information
6.9.2 Thermo Fisher Scientific, Inc. Description and Business Overview
6.9.3 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolio
6.9.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.10 GeneTex
6.10.1 GeneTex Company Information
6.10.2 GeneTex Description and Business Overview
6.10.3 GeneTex Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GeneTex Acute Myeloid Leukemia Biomarker Detection Product Portfolio
6.10.5 GeneTex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acute Myeloid Leukemia Biomarker Detection Industry Chain Analysis
7.2 Acute Myeloid Leukemia Biomarker Detection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acute Myeloid Leukemia Biomarker Detection Production Mode & Process Analysis
7.4 Acute Myeloid Leukemia Biomarker Detection Sales and Marketing
7.4.1 Acute Myeloid Leukemia Biomarker Detection Sales Channels
7.4.2 Acute Myeloid Leukemia Biomarker Detection Distributors
7.5 Acute Myeloid Leukemia Biomarker Detection Customer Analysis
8 Acute Myeloid Leukemia Biomarker Detection Market Dynamics
8.1 Acute Myeloid Leukemia Biomarker Detection Industry Trends
8.2 Acute Myeloid Leukemia Biomarker Detection Market Drivers
8.3 Acute Myeloid Leukemia Biomarker Detection Market Challenges
8.4 Acute Myeloid Leukemia Biomarker Detection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Bio-Rad Laboratories Inc
Laboratory Corporation of America Holdings
Danaher
Neogenomics Laboratories
QIAGEN N V
Thermo Fisher Scientific Inc
GeneTex
Genmark Saghlk Orinleri
Medaysis Company
List of Tables
 Table 1. Global Acute Myeloid Leukemia Biomarker Detection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Acute Myeloid Leukemia Biomarker Detection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Acute Myeloid Leukemia Biomarker Detection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Acute Myeloid Leukemia Biomarker Detection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Acute Myeloid Leukemia Biomarker Detection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Acute Myeloid Leukemia Biomarker Detection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Acute Myeloid Leukemia Biomarker Detection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Acute Myeloid Leukemia Biomarker Detection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Product Type & Application
 Table 12. Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Acute Myeloid Leukemia Biomarker Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Biomarker Detection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Acute Myeloid Leukemia Biomarker Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Acute Myeloid Leukemia Biomarker Detection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Region (2020-2025)
 Table 19. Global Acute Myeloid Leukemia Biomarker Detection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Region (2026-2031)
 Table 21. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Region (2020-2025)
 Table 23. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Region (2026-2031)
 Table 25. North America Acute Myeloid Leukemia Biomarker Detection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Acute Myeloid Leukemia Biomarker Detection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Acute Myeloid Leukemia Biomarker Detection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Acute Myeloid Leukemia Biomarker Detection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Acute Myeloid Leukemia Biomarker Detection Sales (K Units) by Type (2020-2025)
 Table 51. Global Acute Myeloid Leukemia Biomarker Detection Sales (K Units) by Type (2026-2031)
 Table 52. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2020-2025)
 Table 53. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2026-2031)
 Table 54. Global Acute Myeloid Leukemia Biomarker Detection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Acute Myeloid Leukemia Biomarker Detection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Type (2020-2025)
 Table 57. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Type (2026-2031)
 Table 58. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Acute Myeloid Leukemia Biomarker Detection Sales (K Units) by Application (2020-2025)
 Table 61. Global Acute Myeloid Leukemia Biomarker Detection Sales (K Units) by Application (2026-2031)
 Table 62. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2020-2025)
 Table 63. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2026-2031)
 Table 64. Global Acute Myeloid Leukemia Biomarker Detection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Acute Myeloid Leukemia Biomarker Detection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Application (2020-2025)
 Table 67. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Application (2026-2031)
 Table 68. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Laboratories Company Information
 Table 71. Abbott Laboratories Description and Business Overview
 Table 72. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product
 Table 74. Abbott Laboratories Recent Developments/Updates
 Table 75. Bio-Rad Laboratories, Inc. Company Information
 Table 76. Bio-Rad Laboratories, Inc. Description and Business Overview
 Table 77. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product
 Table 79. Bio-Rad Laboratories, Inc. Recent Developments/Updates
 Table 80. Genmark Saghlk Orinleri Company Information
 Table 81. Genmark Saghlk Orinleri Description and Business Overview
 Table 82. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product
 Table 84. Genmark Saghlk Orinleri Recent Developments/Updates
 Table 85. Laboratory Corporation of America Holdings Company Information
 Table 86. Laboratory Corporation of America Holdings Description and Business Overview
 Table 87. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product
 Table 89. Laboratory Corporation of America Holdings Recent Developments/Updates
 Table 90. Danaher Company Information
 Table 91. Danaher Description and Business Overview
 Table 92. Danaher Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Danaher Acute Myeloid Leukemia Biomarker Detection Product
 Table 94. Danaher Recent Developments/Updates
 Table 95. Medaysis Company Company Information
 Table 96. Medaysis Company Description and Business Overview
 Table 97. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product
 Table 99. Medaysis Company Recent Developments/Updates
 Table 100. NeoGenomics Laboratories Company Information
 Table 101. NeoGenomics Laboratories Description and Business Overview
 Table 102. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product
 Table 104. NeoGenomics Laboratories Recent Developments/Updates
 Table 105. QIAGEN N.V. Company Information
 Table 106. QIAGEN N.V. Description and Business Overview
 Table 107. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product
 Table 109. QIAGEN N.V. Recent Developments/Updates
 Table 110. Thermo Fisher Scientific, Inc. Company Information
 Table 111. Thermo Fisher Scientific, Inc. Description and Business Overview
 Table 112. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product
 Table 114. Thermo Fisher Scientific, Inc. Recent Developments/Updates
 Table 115. GeneTex Company Information
 Table 116. GeneTex Description and Business Overview
 Table 117. GeneTex Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. GeneTex Acute Myeloid Leukemia Biomarker Detection Product
 Table 119. GeneTex Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Acute Myeloid Leukemia Biomarker Detection Distributors List
 Table 123. Acute Myeloid Leukemia Biomarker Detection Customers List
 Table 124. Acute Myeloid Leukemia Biomarker Detection Market Trends
 Table 125. Acute Myeloid Leukemia Biomarker Detection Market Drivers
 Table 126. Acute Myeloid Leukemia Biomarker Detection Market Challenges
 Table 127. Acute Myeloid Leukemia Biomarker Detection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Acute Myeloid Leukemia Biomarker Detection
 Figure 2. Global Acute Myeloid Leukemia Biomarker Detection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Acute Myeloid Leukemia Biomarker Detection Market Share by Type: 2024 & 2031
 Figure 4. Next Generation Sequencing Technology Product Picture
 Figure 5. PCR Detection Technology Product Picture
 Figure 6. Global Acute Myeloid Leukemia Biomarker Detection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Acute Myeloid Leukemia Biomarker Detection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Research Institutions
 Figure 10. Other
 Figure 11. Global Acute Myeloid Leukemia Biomarker Detection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Acute Myeloid Leukemia Biomarker Detection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Acute Myeloid Leukemia Biomarker Detection Sales (2020-2031) & (K Units)
 Figure 14. Global Acute Myeloid Leukemia Biomarker Detection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Acute Myeloid Leukemia Biomarker Detection Report Years Considered
 Figure 16. Acute Myeloid Leukemia Biomarker Detection Sales Share by Manufacturers in 2024
 Figure 17. Global Acute Myeloid Leukemia Biomarker Detection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Acute Myeloid Leukemia Biomarker Detection Players: Market Share by Revenue in Acute Myeloid Leukemia Biomarker Detection in 2024
 Figure 19. Acute Myeloid Leukemia Biomarker Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Acute Myeloid Leukemia Biomarker Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2020-2031)
 Figure 22. North America Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Region (2020-2031)
 Figure 34. China Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Acute Myeloid Leukemia Biomarker Detection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Acute Myeloid Leukemia Biomarker Detection by Type (2020-2031)
 Figure 53. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Acute Myeloid Leukemia Biomarker Detection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Acute Myeloid Leukemia Biomarker Detection by Application (2020-2031)
 Figure 56. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Acute Myeloid Leukemia Biomarker Detection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Acute Myeloid Leukemia AML Biomarker Testing Market Research Report 2025
Acute Myeloid Leukemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acute Lymphocytic Leukemia Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acute Myeloid Leukemia AML Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AML Screening Market Research Report 2024
Global Leukemia Molecular Diagnostics Market Research Report 2024
Oncology Blood Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hematologic Malignancies Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hematologic Malignancies Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Cancer Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Molecular Diagnosis of Myelodysplastic Syndrome Market Research Report 2024
Acute Lymphocytic Leukemia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hematologic Malignancies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Hematology Analyzers and Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hematology Testing Product Market Research Report 2024
Global Alzheimer s Disease Biomarker Market Research Report 2024
Medical Imaging Technologies for Oncology Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Automatic Blood Cell Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diagnostic Exosome Biomarker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 5 part Hematology Analyzers Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions